Some applications of the present invention generally relate to medical apparatus. Specifically, some applications of the present invention relate to stent-based electrodes for placement in a blood vessel.
Heart failure is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. The condition impairs quality of life and is a leading cause of hospitalizations and mortality in the western world. Treatment of heart failure is typically aimed at removal of precipitating causes, prevention of deterioration in cardiac function, and control of congestive state.
Hypertension, or chronic high blood pressure, is an extremely prevalent medical condition, which can lead to strokes, heart attacks, and heart failure. There are a variety of treatments that are available for treating hypertension, including lifestyle changes, and medication.
For some applications of the present invention, a stent is placed in a blood vessel. The stent defines at least first, second, and third strut portions disposed along the stent. The first and second strut portions are coupled to one another at a first junction that facilitates bending of the first and second strut portions with respect to one another, and the second and third strut portions are coupled to one another at a second junction that facilitates bending of the second and third strut portions with respect to one another. At least one electrode (typically, at least one pair of electrodes) is disposed on at least an outer surface of the stent. Typically, a current is driven into the blood vessel wall via the electrode.
Typically, the stent is inserted into the blood vessel via a delivery system, such as a catheter. For some applications, the junctions of the stent are configured to cause at least a portion of the outer surface of the stent to assume a convex profile upon protruding from catheter. For some applications, causing the outer surface of the stent to assume the convex profile reduces damage to the vessel wall that could be caused by the distal end of the stent contacting the vessel wall, relative to if the stent were to assume a straight profile upon protruding from the catheter. For some applications, the assumption of the convex profile by the outer surface of the stent brings the electrodes into contact with the vessel wall. For some applications, the junctions of the stent are configured to facilitate retrieval of the stent into the catheter.
It is noted that in the context of the present application, the terms “proximal” and “distal” are to be understood to be with respect to an access point of the stent into the subject's body. Thus, the distal end of the stent is the end of the stent that is further from the access point, and the proximal end of the stent is the end of the stent that is closest to the access point.
For some applications, the stent defines a stent body, and a plurality of posts that protrude longitudinally from a distal end of the stent body. An antenna is disposed annularly on distal portions of the posts, such that the posts separate the stent from the antenna. Typically, the stent electrode is powered via an inductive current that is generated in the antenna. Further typically, the posts, by separating the antenna from the stent body, facilitate an efficient transfer of electrical power to the antenna by reducing an inductive current that may be generated through the stent body and that may interfere with the inductive current in the antenna.
For some applications of the present invention, a stent is configured to be placed inside a subject's blood vessel (e.g., the subject's aorta, pulmonary artery, carotid artery, and/or renal artery), the stent being shaped to define at least one post. At least one coiled electrode is configured to be coupled to the stent by being placed on the post. An electrode-fixation member (e.g., a cap) is configured to fixedly couple the electrode to the post by being placed on the post.
There is therefore provided, in accordance with some applications of the present invention, apparatus for use with a blood vessel of a subject, including:
a stent configured to be placed in the blood vessel, the stent including:
at least one electrode disposed on at least an outer surface of the stent.
For some applications, the strut portions include portions of the stent that provide resistance against longitudinal compression of the stent, that permit radial compression of the stent, and that are less compliant than the junctions of the stent.
For some applications, the junctions include springs.
For some applications, the strut portions include struts that are made from a material selected from the group consisting of: a metal and an alloy, and the junctions include longitudinal locations along the stent body at which the struts of the stent are shaped such as to facilitate bending of the stent at those locations.
For some applications, the junctions are configured to act as joints around which the strut portions flex.
For some applications, the stent includes a fourth strut portion, the fourth strut portion being coupled to the third strut portion at a third junction that facilitates bending of the third and fourth strut portions with respect to one another.
For some applications, the blood vessel includes a curved blood vessel, and the junctions of the stent are configured to facilitate placing of the stent in the curved blood vessel, by facilitating bending of the strut portions of the stent with respect to one another.
For some applications, the stent is for use with a catheter, the stent is configured to be placed inside the blood vessel by being advanced out of a distal end of the catheter, and the junctions of the stent are configured to cause at least a portion of an outer surface of the stent to assume a convex profile upon protruding from catheter.
For some applications, the electrode is disposed on an outer surface of the stent, and, by causing at least the portion of the outer surface of the stent to assume the convex profile upon protruding from catheter, the junctions of the stent are configured to bring the electrode into contact with a wall of the blood vessel.
For some applications, by causing at least the portion of the outer surface of the stent to assume the convex profile upon protruding from catheter, the junctions of the stent are configured to cause an angle that the outer surface of the stent makes with a wall of the blood vessel, as the stent protrudes from the catheter, to be less than if the stent were to assume a straight profile upon protruding from the catheter.
For some applications, by causing the angle that the outer surface of the stent makes with a wall of the blood vessel as the stent protrudes from the catheter, to be less than if the stent were to assume a straight profile upon protruding from the catheter, the junctions are configured to reduce damage to the blood vessel wall.
For some applications, the stent is for use with a catheter, the stent is configured to be partially deployed inside the blood vessel by a distal portion of the stent being advanced out of a distal end of the catheter, and the junctions of the stent are configured, subsequent to the partial deployment of the stent, to facilitate retrieval of the stent into the catheter.
For some applications, the first junction of the stent is configured to facilitate retrieval of the stent into the catheter by allowing the first strut portion of the stent to radially expand, while the second strut portion remains substantially compressed inside the catheter.
For some applications, the second junction of the stent is configured to facilitate retrieval of the stent into the catheter by allowing the second strut portion of the stent to radially expand, while the third strut portion remains substantially compressed inside the catheter.
For some applications, the strut portions include struts that are made from a material selected from the group consisting of: a metal and an alloy, and the junctions include waved strips of the selected material.
For some applications, at least the first junction includes a waved strip of the selected material, the strip having a width of more than 0.1 mm.
For some applications, the strip has a width of less than 1 mm.
There is further provided, in accordance with some applications of the present invention, apparatus for use with a blood vessel of a subject, including:
a stent configured to be placed in the blood vessel, the stent including:
For some applications, the apparatus further includes at least one coiled electrode, the coiled electrode being configured to be coupled to the stent by being placed on one of the posts.
For some applications, a length of each of the posts is greater than 1 mm.
For some applications, the length of each of the posts is greater than 5 mm.
For some applications, a length of each of the posts is less than 20 mm.
For some applications, the length of each of the posts is less than 15 mm.
For some applications, the antenna is configured to receive power by RF energy being transmitted toward the antenna, such as to generate an inductive current through the antenna.
For some applications, the posts are configured, by separating the antenna from the end of the stent body, to reduce a strength of the inductive current that is generated in the stent body, due to a magnetic field that is generated by the inductive current of the antenna.
For some applications, the posts are configured to provide electrical resistance, such that a current from the antenna to the stent body is negligible.
For some applications, the apparatus further includes a control capsule coupled to the stent, the control capsule being configured to be powered using the inductive current of the antenna.
For some applications, the apparatus further includes an electrode coupled to the stent, the control capsule being configured to drive a current into the blood vessel, via the electrode.
For some applications, the apparatus further includes an electrode coupled to the stent, the control capsule being configured to receive an electrical parameter of the blood vessel, via the electrode.
There is additionally provided, in accordance with some applications of the present invention, apparatus for use with a blood vessel of a subject, including:
an annular antenna configured to be placed inside the blood vessel such that radial expansion of the antenna is limited by a circumference of the blood vessel;
a transmitter configured to generate an inductive current in the antenna, by transmitting RF energy toward the antenna; and
a control unit configured to measure the inductive current in the antenna and, in response thereto, to determine a physiological parameter of the subject.
For some applications, the annular antenna includes at least a portion of a stent.
For some applications, the apparatus further includes a stent, the antenna being coupled to the stent.
For some applications, the control unit is configured to determine the physiological parameter of the subject by determining a parameter of the subject selected from the group consisting of: cardiac rate, respiratory rate, blood pressure, and blood vessel pulsation.
For some applications, the control unit is configured to determine the physiological parameter of the subject by interpreting variations in the inductive current that are measured at the antenna as being caused by variations in geometry of the antenna over the course of the subject's cardiac cycle.
For some applications, the control unit is configured to determine the physiological parameter of the subject by determining a respiratory cycle of the subject by analyzing an envelope of a variation of the inductive current with time.
For some applications, the transmitter is configured to transmit the RF energy at a frequency of more than 50 kHz.
For some applications, the transmitter is configured to transmit the RF energy at a frequency of more than 90 kHz.
For some applications, the transmitter is configured to transmit the RF energy at a frequency of less than 100 MHz.
For some applications, the transmitter is configured to transmit the RF energy at a frequency of more than 60 MHz.
There is further provided, in accordance with some applications of the present invention, a method for use with a blood vessel of a subject, including:
providing:
There is further provided, in accordance with some applications of the present invention, a method for use with a blood vessel of a subject, including:
providing a stent that includes:
placing the stent inside the blood vessel.
There is additionally provided, in accordance with some applications of the present invention, a method for use with a blood vessel of a subject, comprising:
placing into the blood vessel:
operating a transmitter:
For some applications, placing the stent and the antenna into the blood vessel includes reducing a strength of the inductive current that is generated in the stent body, due to a magnetic field that is generated by the antenna, by placing the stent and the antenna such that the antenna is separated from the stent body.
For some applications, placing the stent and the antenna into the blood vessel includes placing the stent and the antenna into the blood vessel such that the stent body is separated from the antenna by a distance that is greater than 1 mm.
For some applications, placing the stent and the antenna into the blood vessel includes placing the stent and the antenna into the blood vessel such that the stent body is separated from the antenna by a distance that is greater than 5 mm.
For some applications, placing the stent and the antenna into the blood vessel includes placing the stent and the antenna into the blood vessel such that the stent body is separated from the antenna by a distance that is less than 20 mm.
For some applications, placing the stent and the antenna into the blood vessel includes placing the stent and the antenna into the blood vessel such that the stent body is separated from the antenna by a distance that is less than 15 mm.
There is further provided, in accordance with some applications of the present invention, a method for use with an annular antenna that has been placed in a blood vessel and allowed to expand radially, such that radial expansion of the antenna is limited by a circumference of the blood vessel, the method comprising:
generating an inductive current in the antenna, by transmitting RF energy toward the antenna;
measuring the inductive current in the antenna; and
in response thereto, determining a physiological parameter of the subject.
There is further provided, in accordance with some applications of the present invention, apparatus, including:
a stent shaped to define struts and at least one post;
a coiled electrode configured to be coupled to the stent by being placed on the post; and
an electrode-fixation member configured to fixedly couple the coiled electrode to the post by being placed on the post.
The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
Reference is now made to
It is noted that
Similarly, although
For some applications, electrodes 22 are placed in contact with an aortic site, which is typically as described in U.S. Ser. No. 13/210,778 (published as US 2012/0035679), U.S. Ser. No. 12/957,799 to Gross (published as US 2011/0137370), and/or U.S. Ser. No. 12/792,227 to Gross (published as US 2010/0305392), all of which applications are incorporated herein by reference. Thus, the aortic site is typically between the bifurcation of the aorta with the left subclavian artery and the bifurcation of the aorta with the fifth intercostal artery. Further typically, the aortic site is between the bifurcation of the aorta with the left subclavian artery and the bifurcation of the aorta with the fourth intercostal artery, e.g., between the bifurcation of the aorta with the left subclavian artery and the bifurcation of the aorta with the first intercostal artery. For some applications, the aortic site is between the bifurcations of the aorta with the first and fifth intercostal arteries.
For some applications, a current is driven into the subject's aorta, e.g., in order to treat the subject for a condition such as congestive heart failure, diastolic heart failure, and/or hypertension, e.g., as described in as described in U.S. Ser. No. 13/210,778 (published as US 2012/0035679), U.S. Ser. No. 12/957,799 to Gross (published as US 2011/0137370), and/or U.S. Ser. No. 12/792,227 to Gross (published as US 2010/0305392), all of which applications are incorporated herein by reference. For some applications, the subject's cardiac cycle is determined by detecting an electrical signal from the subject's aorta, via electrodes 22, and deriving the subject's ECG and/or blood pressure from the electrical signal detected at the aorta, e.g., in accordance with techniques described in U.S. Ser. No. 12/792,227 to Gross (published as US 2010/0305392). For some applications, electrical stimulation is applied to the aorta in coordination with the subject's cardiac cycle, based upon the electrical signal detected at the aorta.
For some applications, electrodes are placed at a different location (e.g., a different location within the aorta, or within a different blood vessel of the subject, as described hereinabove), and a current is driven into the different location via the electrodes, or an electrical signal is detected from the different location via the electrodes. For example, a current may be driven into the different location in order to treat the subject for congestive heart failure, and/or hypertension.
Typically, the compliance of stent 20 varies along the length of the stent. For some applications, the compliance of the stent varies along the length of the stent in a manner that conforms with local stresses exerted on the stent by collagen fibers of the blood vessel. For some applications, the compliance of the stent varies along the length of the stent in a manner that facilitates placement of the stent in a curved blood vessel, the stent being configured to conform with the local shape of the blood vessel.
Typically, stent 20 includes a plurality of strut portions along the length of the stent, and the strut portions are coupled to each other at junctions 37, for example, junctions that include springs 38. Typically, the compliance of the stent at the junctions is greater than the compliance of the stent at the strut portions. For some applications, the stent is configured to be placed in a curved blood vessel. For some applications, the compliance of the stent at the junctions facilitates curvature of the stent that conforms with the curvature of the blood vessel. For example, the compliance of the stent at the junctions may facilitate curvature of the stent such that local longitudinal axes of respective strut portions of the stent are aligned with local longitudinal axes of a curved blood vessel. For some applications, the compliance of the stent at the junctions provides flexibility to the stent while the stent is being advanced through a delivery system (such as a catheter).
For example, with reference to
It is noted that in the context of the present application, the term “spring” should not necessarily be understood to be limited to denoting an object having a particular shape. Rather, the term “spring” should be understood to denote a portion of the stent that stores potential energy when it is bent and releases it when the restraining force is removed. It is further noted that, in
Stent 20 is typically configured to be placed inside the blood vessel (e.g., the aorta) percutaneously using a delivery system, e.g., using a 12 Fr-20 Fr catheter (e.g., a 16 Fr catheter). Typically, upon being placed inside the blood vessel, the stent is partially deployed, such that (a) electrodes 22 contact the wall of the blood vessel at a given location within the blood vessel, and (b) a proximal portion of the stent is disposed inside the catheter, such that the stent may be retrieved into the catheter. The response of the subject to electrical stimulation of the blood vessel at the current location of the electrodes within the blood vessel is determined. In response thereto, the stent is (a) fully deployed at the current location of the stent (b) retrieved into the catheter and redeployed at a different location within the blood vessel, or (c) retrieved into the catheter and removed from the subject's body (e.g., if the subject does not respond in a suitable manner to electrical stimulation of the blood vessel at any locations at which the stent is deployed). For some applications, the junctions of the stent facilitate the partial deployment of the stent such that (a) electrodes 22 contact the wall of the blood vessel at a given location within the blood vessel, and (b) a proximal portion of the stent is disposed inside the catheter, such that the stent may be retrieved into the catheter, as described in further detail below with reference to
Typically, the compliance of stent 20 is such that pulsation of the blood vessel is substantially maintained upon the stent being deployed inside the blood vessel. Further typically, the stent and components coupled thereto (such as control capsule 30) are shaped such as to substantially maintain blood flow through the blood vessel upon deployment of the stent inside the blood vessel.
For some applications, stent 20 is cut from a nitinol tube (or a tube made from a different material, such as stainless steel) having a wall thickness of more than 0.3 mm (e.g., more than 0.4 mm), and/or less than 0.7 mm (e.g., less than 0.6 mm). For some applications the length of the stent is more than 25 mm (e.g., more than 30 mm), and/or less than 100 mm (e.g., less than 40 mm) For some applications, the stent has an outer diameter of more than 10 mm (e.g., more than 15 mm), and/or less than 35 mm (e.g., less than 25 mm). Typically, the stent has a crimped profile of less than 18 Fr (e.g., 12 Fr or less), and/or more than 8 Fr (e.g., 10 Fr or more).
For some applications, a transmitter 24 (
For some applications, one or more portions of stent 20 function as antenna 28. For example, the stent may be cut from a nitinol tube and a portion of the tube functions as the antenna. Alternatively, an antenna may be coupled to the stent, e.g., using techniques described herein. For some applications, the diameter of the blood vessel at the antenna and/or hemodynamic parameters are measured using the antenna, as described in further detail hereinbelow, with reference to
For some applications, capsule 30 is coupled to the stent mechanically, e.g., using a locking mechanism, adhesive (e.g., epoxy), suturing, and/or by pressing the capsule against struts of the stent, such that the capsule becomes coupled to the stent by deforming to conform with the shape of the stent struts. For some applications, the capsule is coupled to a fabric sleeve (e.g., by being printed onto the sleeve) and the sleeve is coupled (e.g., sutured) to the stent, e.g., as described hereinbelow.
For some applications, a control unit for driving electrode 22 is disposed in a subcutaneously implanted housing 50. The control unit is coupled, via a lead 52 to transmitter 24 (e.g., a transmitting coil, as shown) that is implanted in vein 26 that is in the vicinity of the blood vessel (e.g., the aorta). For example, the transmitter may be placed in the innominate vein (also called the left brachiocephalic vein), placement of the transmitter in the innominate vein being performed via the left subclavian vein. The control unit wirelessly drives the electrodes, receives a signal from the electrode, and/or powers circuitry associated with the electrode (e.g., circuitry of control capsule 30) by transmitting a wireless signal to antenna 28, via transmitter 24. Typically, the transmitter is placed inside the vein such that it is at a distance from the intra-arterial electrodes of more than 2 cm and/or less than 5 cm (e.g., 2-5 cm), or more than 5 cm and/or less than 20 cm (e.g., 5-20 cm). For example, the transmitter may be placed in the pulmonary vein, innominate vein, vena cava, jugular vein, and/or subclavian vein.
For some applications, housing 50 which houses the control unit is implanted (e.g., implanted subcutaneously) in the vicinity of electrode 22, e.g., within 10 cm of the electrode. For some applications, housing 50 is disposed on a chest belt that is worn on the subject's chest, such that the housing is outside the subject's body, but within 15 cm of the electrode. The control unit wirelessly drives the electrode, receives a signal from the electrode, and/or powers circuitry associated with the electrode (e.g., circuitry of control capsule 30), by transmitting a wireless signal to antenna 28.
For some applications, the control unit is disposed inside housing 50 and is implanted subcutaneously inside the subject, as described hereinabove. Parameters of the control unit may be adjusted by transmitting a signal to the control unit from outside the subject's body. Alternatively or additionally, electrical power may be supplied to the subcutaneously implanted control unit, by transmitting a signal to the control unit from outside the subject's body.
For some applications, transmitter 24 is mounted on a support structure (such as a nitinol ring) in order to orient the transmitter in a suitable orientation for transmitting a signal to antenna 28, which is coupled to the electrode. For example, the transmitter may include a coil that is mounted on the support structure such that a plane that is defined by the coil is at an angle of greater than 10 degrees from a plane that is perpendicular to the local longitudinal axis of the vein in which the transmitter is placed. Alternatively, the transmitter coil is oriented with respect to the support structure such that the plane defined by the coil is generally perpendicular to the local longitudinal axis of the vein.
For some applications, transmitter coil 24 is placed inside the vein such that the plane defined by the coil is at an angle of greater than 10 degrees from a plane that is perpendicular to the local longitudinal axis of the vein, without mounting the coil on a support structure. Alternatively, the coil is placed inside the vein such that the plane defined by the coil is generally perpendicular to the local longitudinal axis of the vein, without mounting the coil on a support structure. Typically, the transmitter coil is placed in the vein (by being mounted on a support structure, or not by being mounted on a support structure) such that the plane defined by the transmitter coil is generally perpendicular to the plane defined by antenna 28, which is placed in the subject's artery.
Reference is now made to
Stent 20 as shown in
For some applications, the first, second and third junctions of the stent facilitate the partial deployment of the stent such that (a) electrodes 22 contact the wall of the blood vessel at a given location within the blood vessel, and (b) a proximal portion of the stent is disposed inside the catheter, such that the stent may be retrieved into the catheter, as described in further detail below with reference to
It is noted that for some applications, a stent having more than three junctions (and correspondingly, more than four strut portions) is used. Typically, the number of junctions that the stent defines increases as the length of the stent increases. For some applications, the length of the stent that is used increases as the diameter of the vessel in which the stent is to be placed increases, in order to facilitate greater radial expansion of the distal end of the stent during partial deployment of the stent. In addition, the length of the stent that is used increases as the curvature of the vessel in which the stent is to be placed increases, in order to facilitate greater radial expansion of the distal end of the stent during partial deployment of the stent. In a curved vessel, it may be necessary to radially expand the stent to a greater diameter than is necessary in a similar sized straight vessel, in order to bring the electrodes into contact with a portion of the vessel wall that is curving away from the distal end of the delivery system. Furthermore, in a curved vessel, the distal end of the delivery system (e.g., the catheter), via which the stent is inserted, is typically disposed closer to the wall on one side of the vessel, and is not disposed in the center of the vessel, due to the delivery system distal end (e.g., the catheter tip) typically being substantially straight, and the vessel being curved. Therefore, in a curved vessel, it may be necessary to radially expand the stent to a greater diameter than is necessary in a similar sized straight vessel, in order to bring the electrodes into contact with the wall that is further from the distal end of the delivery system.
As shown in
Reference is now made to
For some applications, one or more posts 64 are defined by first strut portion 32 of stent 20, the first strut portion being configured to be placed in the subject's aortic arch, for example, as shown in
Reference is now made to
Reference is now made to
For some applications, stent 20 includes first, second, third, and fourth strut portions, and, correspondingly three junctions 37A, 37B, and 37C, e.g., as described herein with reference to
For some applications, both first and second strut portions of the stent define posts, to which coiled electrodes 22 are couplable, e.g., as shown in
In accordance with respective applications, a single antenna 28 is coupled to the stent (as shown in
In general, the scope of the present invention includes stents having any number of strut portions coupled to each other at junctions (e.g., via springs), and any number of antennas, posts for supporting electrodes, and/or electrodes (e.g., coiled electrodes, as shown in
For some applications, one or more components are coupled to stent 20, by coupling the components to a cuff (e.g., by printing the components on the cuff, by adhering the components to the cuff using adhesive, and/or by suturing the components to the cuff) and coupling the cuff to the stent (e.g., by suturing the cuff to the stent, or adhering the cuff the stent using adhesive), e.g., as described in U.S. Provisional Patent Application 61/532,660 to Dagan, which is incorporated herein by reference. For example, antenna 28, electrodes 22, and/or capsule 30 may be coupled to the stent in the aforementioned manner. For some applications, a cuff is used that is configured to be coupled to the stent along substantially the entire length of the stent. Alternatively, a cuff such is used that is configured to be coupled to a portion of the length of the stent, e.g., first strut portion 32 of the stent.
Reference is now made to
For some applications, the posts at least partially electrically insulate the antenna from the stent body, due to electrical resistance provided by the posts or portions thereof. For some applications, posts 92, or at least portions thereof, are formed from a material that is an electrical insulator, such as a plastic. Typically, the posts are formed of nitinol, and the nitinol posts provide electrical resistance that is such that the current from the antenna to the stent body, through the posts, is relatively low, e.g., negligible, and/or substantially zero.
As described hereinabove, for some applications antenna 28 is used to receive electrical power for powering the control capsule 30 to drive a current via electrodes 22. Typically, the antenna receives power via inductive coupling, e.g., by transmitter 24 (shown in
For some applications, a length L (
Typically, coiled electrodes 22 are coupled to stent 20 by being placed around posts 92, for example, by using a construction as shown in
Typically, antenna 28 is wiredly coupled to control capsule 30 (wires not shown), and the control capsule is powered using the inductive current of the antenna. For some applications, the inductive current of the antenna is the only source of power for the control capsule. The control capsule is typically configured to drive a current into the blood vessel via electrode 22 (e.g., to stimulate the blood vessel), and/or to receive an electrical parameter of the blood vessel via the electrode. For some applications, stent body 90 includes a wire holder 98 that is configured to hold in place with respect to the stent body the wires that couple the antenna to the control capsule, by the wires being threaded through slots defined by the wire holder.
Reference is now made to
Stent 20 as shown in
Stent 20 as shown in
Reference is now made to
Reference is now made to
Reference is now made to
For some applications, the coiled electrode is disposed around an insulting layer 102. For example, the insulating layer may be composed of polyether ether ketone (PEEK), and/or or another plastic. The insulating layer is typically hollow, such that the insulating layer can be placed on post 92 of stent 20. For some applications, the insulating layer is shaped to define an inner cross-section having a square shape. The square shaped cross-section of the inner surface is configured to prevent rotation of the electrode construction about post 92. The insulating layer acts in a generally similar manner to insulation tube 60 described hereinabove, with reference to
Typically, electrode construction 100 defines a tip-encapsulation portion 106 configured to hold the distal end of coiled electrode 22 in place with respect to insulating layer 102, by encapsulating the distal end of electrode 22. Further typically, electrode construction 100 defines a base-encapsulation portion 104 configured to hold the proximal end of coiled electrode 22 in place with respect to insulating layer 102, by encapsulating the proximal end of electrode 22. Typically, a proximal end 110 of the coiled electrode passes through the base-encapsulation portion. A wire from the control capsule is electrically coupled to the proximal end of the coiled electrode.
For some applications, the electrode construction defines an outer insulating layer 108. The outer insulating layer is placed around the side of the coiled electrode that faces the inside of the stent, in order to electrically insulate the electrode from the subject's blood.
Reference is now made to
As described hereinabove, stent 20 is typically configured to be placed inside the blood vessel (e.g., the aorta) percutaneously, e.g., using a 12 Fr-20 Fr catheter (e.g., a 16 Fr catheter). Typically, upon being placed inside the blood vessel, the stent is partially deployed, such that (a) electrodes 22 (not shown, but which are typically coupled to first, distal-most strut portion 32) contact the wall of the blood vessel at a given location within the blood vessel, and (b) a proximal portion of the stent is disposed inside the catheter, such that the stent may be retrieved into the catheter. The response of the subject to electrical stimulation of the blood vessel at the current location of the electrodes within the blood vessel is determined. In response thereto, the stent is (a) fully deployed at the current location of the stent (b) retrieved into the catheter and redeployed at a different location within the blood vessel, or (c) retrieved into the catheter and removed from the subject's body (e.g., if the subject does not respond in a suitable manner to electrical stimulation of the blood vessel at any locations at which the stent is deployed).
For some applications, junctions 37 of stent 20 are configured to cause at least a portion of the outer surface of the stent to assume a convex profile upon protruding from catheter. For example, as shown in the transition from
For some applications, junctions 37 of the stent are configured to facilitate retrieval of the stent into the catheter. For example, as shown in the transition from
For some applications, first junction 37A of stent 20 is configured to reduce an angle that posts 92 of the stent make with the blood vessel wall as the posts protrude from the distal end of the delivery device, relative to the angle that the posts would make with the blood vessel wall in the absence of the junction. For some applications, in this manner, the first junction reduces injury to the blood vessel wall that may be caused by the posts, relative to if the posts were to make a larger angle with the blood vessel wall. For some applications, the first junction includes waved strips of nitinol (or another alloy or metal) that function as springs, each of the strips having a width that is greater than 0.1 mm, and/or less than 1 mm (e.g., less than 0.6 mm).
Reference is now made to
As described hereinabove, with reference to
As described hereinabove, typically, the number of junctions that the stent defines increases as the length of the stent increases. For some applications, the length of the stent that is used increases as the diameter of the vessel in which the stent is to be placed increases, in order to facilitate greater radial expansion of the distal end of the stent during partial deployment of the stent. In addition, the length of the stent that is used increases as the curvature of the vessel in which the stent is to be placed increases, in order to facilitate greater radial expansion of the distal end of the stent during partial deployment of the stent. In a curved vessel, it may be necessary to radially expand the stent to a greater diameter than is necessary in a similar sized straight vessel, in order to bring the electrodes into contact with a portion of the vessel wall that is curving away from the distal end of the delivery system. Furthermore, in a curved vessel, the distal end of the delivery system via which the stent is inserted is typically disposed closer to the wall on one side of the vessel, and not disposed in the center of the vessel, due to the catheter tip typically being substantially straight, and the vessel being curved. Therefore, in a curved vessel, it may be necessary to radially expand the stent to a greater diameter than is necessary in a similar sized straight vessel, in order to bring the electrodes into contact with the wall that is further from the distal end of the delivery system.
Reference is now made to
An antenna that was disposed on a stent was placed inside the aorta of a sheep. A transmitter that was disposed outside the sheep's body was used to transmit RF energy toward the antenna. Wires were used to connect the antenna to a computer that was disposed outside of the sheep's body, in order to record the inductive voltage that was generated at the antenna, as a result of the RF energy that was transmitted toward the antenna. Simultaneously with the detection of the inductive voltage at the antenna, the sheep's blood pressure was measured using a sphygmomanometer that was connected to a leg of the sheep.
The bottom curve of the graph of
The bottom curve of the graph of
Therefore, in accordance with some applications of the present invention, an annular antenna is placed inside a blood vessel on a stent, such that the radial expansion of the stent (and therefore the antenna) is limited by the circumference of the blood vessel. Alternatively, a stent, or at least a portion thereof, is configured to act as an antenna, the stent being placed inside a blood vessel such that the radial expansion of the stent is limited by the circumference of the blood vessel. An inductive current is generated in the antenna by transmitting RF energy toward the antenna. For some applications, RF energy is directed toward the antenna, the RF energy having a frequency of more than 50 kHz (e.g., more than 90 kHz), and/or less than 100 MHz (e.g., less than 60 MHz). The inductive current that is generated at the antenna is measured. Variations in the inductive current that are measured at the antenna are interpreted as being caused by variations in the geometry of the antenna over the course of the subject's cardiac cycle. For example, variations in the inductive current having a frequency of more than 0.5 Hz and/or less than 1.5 Hz are interpreted as being caused by variations in the geometry of the antenna over the course of the subject's cardiac cycle. For some applications, variations in the inductive current having a frequency of more than 0.05 Hz and/or less than 0.3 Hz are interpreted as being caused by variations in the geometry of the antenna over the course of the subject's respiratory cycle. In response to variations in the inductive current of the antenna, physiological parameters of the subject, e.g., hemodynamic physiological parameters of the subject, are derived. For example, the subject's cardiac rate, respiratory rate, blood pressure, blood vessel pulsation, and/or other parameters of the subject may be derived.
It is noted that, although some applications of the present invention have been described as being used in conjunction with a stent, the scope of the present invention includes applying the apparatus and methods described herein to a stent graft, mutatis mutandis. For example, a stent graft that defines strut portions and junctions may be used, and/or an antenna may be coupled to the body of a stent graft via posts that longitudinally separate the antenna from a distal end of the body of the stent graft, in accordance with the techniques described hereinabove.
Although some applications of the present invention have been described with respect to placing stent 20 inside a subject's aorta, the scope of the present invention includes placing stent 20 in other blood vessel's of a subject's body, mutatis mutandis.
For some applications, the techniques described herein are practiced in combination with techniques described in WO 07/013065 to Gross, which is incorporated herein by reference. For some applications, the techniques described herein are practiced in combination with the techniques described in WO 09/095918, entitled “Peristaltic pump for treatment of erectile dysfunction,” to Gross, which claims priority from U.S. Patent Application 2009/0198097 to Gross, the PCT application and the U.S. application being incorporated herein by reference. For some applications, the techniques described herein are practiced in combination with the techniques described in U.S. Patent Application 2009/0198097 to Gross, which is incorporated herein by reference. For some applications, the techniques described herein are practiced in combination with the techniques described in U.S. 2012/0035679 to Dagan, U.S. 2011/0137370 to Gross, and/or in U.S. 2010/0305392 to Gross, all of which applications are incorporated herein by reference.
For some applications, the methods described herein are performed in combination with the techniques described in WO 09/095920 to Gross, which is incorporated herein by reference.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a continuation of U.S. Ser. No. 13/741,154 to Dagan ( issued as U.S. Pat. No. 9,526,637 to Dagan), which is the U.S. national phase of International Application PCT/IL2012/000336 to Dagan (published as WO 13/035092), filed Sep. 09, 2012, which claims priority from U.S. Provisional Patent Application 61/532,660 to Dagan, filed Sept. 09, 2011, entitled, “Wireless endovascular stent-based electrodes.” The present application is related to U.S. Ser. No. 13/210,778 to Dagan (issued as U.S. Pat. No. 8,626,290), filed Aug. 16, 2011, which is a continuation-in-part of U.S. Ser. No. 12/957,799 to Gross (issued as U.S. Pat. No. 8,626,299), filed Dec. 1, 2010, entitled “Thoracic aorta and vagus nerve stimulation,” which is a continuation-in-part of U.S. Ser. No. 12/792,227 to Gross (published as US 2010/0305392, now abandoned), filed Jun. 2, 2010, entitled “Thoracic aorta and vagus nerve stimulation,” which claims the benefit of (a) U.S. Provisional Patent Application 61/183,319 to Reisner, filed Jun. 2, 2009, entitled “Thoracic aorta and vagus nerve stimulation,” and (b) U.S. Provisional Patent Application 61/331,453 to Dagan, filed May 5, 2010, entitled “Thoracic aorta and vagus nerve stimulation.” All of the above-referenced applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3650277 | Sjostrand et al. | Mar 1972 | A |
3661148 | Kolin | May 1972 | A |
4154227 | Krause et al. | May 1979 | A |
4201219 | Bozal Gonzalez et al. | May 1980 | A |
4474630 | Planck et al. | Oct 1984 | A |
4692148 | Kantrowitz et al. | Sep 1987 | A |
4791931 | Slate | Dec 1988 | A |
4809681 | Kantrowitz et al. | Mar 1989 | A |
4821723 | Baker, Jr. et al. | Apr 1989 | A |
4848352 | Pohndorf et al. | Jul 1989 | A |
4938766 | Jarvik | Jul 1990 | A |
5192271 | Kalb et al. | Mar 1993 | A |
5199428 | Obel et al. | Apr 1993 | A |
5224491 | Mehra | Jul 1993 | A |
5265011 | O'Rourke | Nov 1993 | A |
5265601 | Mehra | Nov 1993 | A |
5306292 | Lindegren | Apr 1994 | A |
5324323 | Bui | Jun 1994 | A |
5330507 | Schwartz | Jul 1994 | A |
5372573 | Habib | Dec 1994 | A |
5411031 | Yomtov | May 1995 | A |
5423871 | Hoegnelid et al. | Jun 1995 | A |
5458626 | Krause | Oct 1995 | A |
5487760 | Villafana | Jan 1996 | A |
5540730 | Terry, Jr. et al. | Jul 1996 | A |
5571150 | Wernicke et al. | Nov 1996 | A |
5612314 | Stamler et al. | Mar 1997 | A |
5645839 | Chobanian et al. | Jul 1997 | A |
5649966 | Noren et al. | Jul 1997 | A |
5651378 | Matheny et al. | Jul 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5690681 | Geddes et al. | Nov 1997 | A |
5707400 | Terry, Jr. et al. | Jan 1998 | A |
5735887 | Barreras, Sr. et al. | Apr 1998 | A |
5762599 | Sohn | Jun 1998 | A |
5782774 | Shmulewitz | Jul 1998 | A |
5800464 | Kieval | Sep 1998 | A |
5800502 | Boutos | Sep 1998 | A |
5814089 | Stokes et al. | Sep 1998 | A |
5873865 | Horzewski et al. | Feb 1999 | A |
5900433 | Igo et al. | May 1999 | A |
5902712 | Burns et al. | May 1999 | A |
5904711 | Flom et al. | May 1999 | A |
5904712 | Axelgaard | May 1999 | A |
5906641 | Thompson et al. | May 1999 | A |
5913876 | Taylor et al. | Jun 1999 | A |
5935077 | Ogle | Aug 1999 | A |
5948006 | Mann | Sep 1999 | A |
5994444 | Trescony et al. | Nov 1999 | A |
6014589 | Farley et al. | Jan 2000 | A |
6023640 | Ross | Feb 2000 | A |
6029091 | de la Rama et al. | Feb 2000 | A |
6038485 | Axelgaard | Mar 2000 | A |
6053873 | Govari et al. | Apr 2000 | A |
6058331 | King | May 2000 | A |
6073048 | Kieval et al. | Jun 2000 | A |
6086527 | Talpade | Jul 2000 | A |
6104956 | Naritoku et al. | Aug 2000 | A |
6106477 | Miesel et al. | Aug 2000 | A |
6120520 | Saadat et al. | Sep 2000 | A |
6141587 | Mower | Oct 2000 | A |
6178349 | Kieval | Jan 2001 | B1 |
6200259 | March | Mar 2001 | B1 |
6201991 | Chekanov | Mar 2001 | B1 |
6231516 | Keilman et al. | May 2001 | B1 |
6245103 | Stinson | Jun 2001 | B1 |
6246911 | Seligman | Jun 2001 | B1 |
6270524 | Kim | Aug 2001 | B1 |
6273910 | Limon | Aug 2001 | B1 |
6277078 | Porat et al. | Aug 2001 | B1 |
6292695 | Webster, Jr. et al. | Sep 2001 | B1 |
6317631 | Ben-Haim et al. | Nov 2001 | B1 |
6339725 | Naritoku et al. | Jan 2002 | B1 |
6347247 | Dev et al. | Feb 2002 | B1 |
6411845 | Mower | Jun 2002 | B1 |
6418348 | Witte | Jul 2002 | B1 |
6423084 | St. Germain | Jul 2002 | B1 |
6440059 | Haas et al. | Aug 2002 | B1 |
6445953 | Bulkes et al. | Sep 2002 | B1 |
6463323 | Conrad-Vlasak et al. | Oct 2002 | B1 |
6473644 | Terry, Jr. et al. | Oct 2002 | B1 |
6480747 | Schmidt | Nov 2002 | B2 |
6485524 | Strecker | Nov 2002 | B2 |
6496732 | Wallace | Dec 2002 | B1 |
6522926 | Kieval et al. | Feb 2003 | B1 |
6532388 | Hill et al. | Mar 2003 | B1 |
6582461 | Burmeister et al. | Jun 2003 | B1 |
6611715 | Boveja | Aug 2003 | B1 |
6615085 | Boveja | Sep 2003 | B1 |
6616613 | Goodman | Sep 2003 | B1 |
6616624 | Kieval | Sep 2003 | B1 |
6622041 | Terry, Jr. et al. | Sep 2003 | B2 |
6626935 | Ainsworth et al. | Sep 2003 | B1 |
6631296 | Parramon et al. | Oct 2003 | B1 |
6632991 | Chen | Oct 2003 | B2 |
6647287 | Peel, III et al. | Nov 2003 | B1 |
6656960 | Puskas | Dec 2003 | B2 |
6668191 | Boveja | Dec 2003 | B1 |
6682480 | Habib et al. | Jan 2004 | B1 |
6721603 | Zabara et al. | Apr 2004 | B2 |
6735474 | Loeb et al. | May 2004 | B1 |
6810286 | Donovan et al. | Oct 2004 | B2 |
6824561 | Soykan et al. | Nov 2004 | B2 |
6845267 | Harrison et al. | Jan 2005 | B2 |
6850801 | Kieval et al. | Feb 2005 | B2 |
6865416 | Dev et al. | Mar 2005 | B2 |
6871092 | Piccone | Mar 2005 | B2 |
6885895 | Whitehurst et al. | Apr 2005 | B1 |
6934583 | Weinberg et al. | Aug 2005 | B2 |
6939345 | Kenknight et al. | Sep 2005 | B2 |
6947792 | Ben-Haim et al. | Sep 2005 | B2 |
6985774 | Kieval et al. | Jan 2006 | B2 |
7044981 | Liu et al. | May 2006 | B2 |
7062318 | Ben-Haim et al. | Jun 2006 | B2 |
7076307 | Boveja et al. | Jul 2006 | B2 |
7079901 | Loftin et al. | Jul 2006 | B1 |
7082336 | Ransbury et al. | Jul 2006 | B2 |
7090648 | Sackner et al. | Aug 2006 | B2 |
7123961 | Kroll et al. | Oct 2006 | B1 |
7149574 | Yun et al. | Dec 2006 | B2 |
7158832 | Kieval et al. | Jan 2007 | B2 |
7167751 | Whitehurst et al. | Jan 2007 | B1 |
7191007 | Desai et al. | Mar 2007 | B2 |
7191012 | Boveja et al. | Mar 2007 | B2 |
7201719 | Feliss et al. | Apr 2007 | B2 |
7206637 | Salo | Apr 2007 | B2 |
7225019 | Jahns et al. | May 2007 | B2 |
7228167 | Kara et al. | Jun 2007 | B2 |
7229403 | Schock et al. | Jun 2007 | B2 |
7263405 | Boveja et al. | Aug 2007 | B2 |
7269457 | Shafer et al. | Sep 2007 | B2 |
7277761 | Shelchuk | Oct 2007 | B2 |
7291113 | Satoh et al. | Nov 2007 | B2 |
7292886 | Kroll | Nov 2007 | B1 |
7299091 | Barrett et al. | Nov 2007 | B2 |
7321793 | Ben Ezra et al. | Jan 2008 | B2 |
7363076 | Yun et al. | Apr 2008 | B2 |
7367970 | Govari et al. | May 2008 | B2 |
7389149 | Rossing et al. | Jun 2008 | B2 |
7395119 | Hagen et al. | Jul 2008 | B2 |
7444183 | Knudson et al. | Oct 2008 | B2 |
7452334 | Gianchandani et al. | Nov 2008 | B2 |
7471986 | Hatlestad | Dec 2008 | B2 |
7476200 | Tal | Jan 2009 | B2 |
7480532 | Kieval et al. | Jan 2009 | B2 |
7486991 | Libbus et al. | Feb 2009 | B2 |
7499747 | Kieval et al. | Mar 2009 | B2 |
7499748 | Moffitt et al. | Mar 2009 | B2 |
7502650 | Kieval | Mar 2009 | B2 |
7519421 | Denker et al. | Apr 2009 | B2 |
7532932 | Denker et al. | May 2009 | B2 |
7555344 | Maschino et al. | Jun 2009 | B2 |
7561918 | Armstrong et al. | Jul 2009 | B2 |
7570999 | Libbus et al. | Aug 2009 | B2 |
7613511 | Wu et al. | Nov 2009 | B2 |
7613515 | Knudson et al. | Nov 2009 | B2 |
7616997 | Kieval et al. | Nov 2009 | B2 |
7617003 | Caparso et al. | Nov 2009 | B2 |
7623926 | Rossing et al. | Nov 2009 | B2 |
7634315 | Cholette | Dec 2009 | B2 |
7706875 | Buras et al. | Apr 2010 | B2 |
7706884 | Libbus | Apr 2010 | B2 |
7706886 | Morimoto et al. | Apr 2010 | B2 |
7715915 | Ryu et al. | May 2010 | B1 |
7720547 | Denker et al. | May 2010 | B2 |
7725194 | Klostermann et al. | May 2010 | B2 |
7738961 | Sharma | Jun 2010 | B2 |
7747302 | Milledge et al. | Jun 2010 | B2 |
7765000 | Zhang et al. | Jul 2010 | B2 |
7765008 | Ben-Haim et al. | Jul 2010 | B2 |
7769446 | Moffitt et al. | Aug 2010 | B2 |
7780719 | Killion et al. | Aug 2010 | B2 |
7801604 | Brockway et al. | Sep 2010 | B2 |
7811221 | Gross | Oct 2010 | B2 |
7813805 | Farazi | Oct 2010 | B1 |
7813812 | Kieval et al. | Oct 2010 | B2 |
7826899 | Ryu et al. | Nov 2010 | B1 |
7840282 | Williams et al. | Nov 2010 | B2 |
7848820 | Abrahamson | Dec 2010 | B2 |
7856273 | Maschino et al. | Dec 2010 | B2 |
7860566 | Mazgalev et al. | Dec 2010 | B2 |
7869870 | Farazi | Jan 2011 | B1 |
7881782 | Libbus et al. | Feb 2011 | B2 |
7881792 | Farazi | Feb 2011 | B1 |
7894902 | Rom | Feb 2011 | B2 |
7899554 | Williams et al. | Mar 2011 | B2 |
7949400 | Kieval et al. | May 2011 | B2 |
7991474 | Aldrich et al. | Aug 2011 | B2 |
8046085 | Knudson et al. | Oct 2011 | B2 |
8065019 | Marnfeldt et al. | Nov 2011 | B2 |
8086314 | Kieval | Dec 2011 | B1 |
8095218 | Gross et al. | Jan 2012 | B2 |
8121692 | Haefner et al. | Feb 2012 | B2 |
8131362 | Moffitt et al. | Mar 2012 | B2 |
8150508 | Craig | Apr 2012 | B2 |
8160701 | Zhao et al. | Apr 2012 | B2 |
8175705 | Libbus | May 2012 | B2 |
8224437 | Kieval et al. | Jul 2012 | B2 |
8244378 | Bly et al. | Aug 2012 | B2 |
8249705 | Kieval et al. | Aug 2012 | B1 |
8290595 | Kieval et al. | Oct 2012 | B2 |
8386038 | Bianchi et al. | Feb 2013 | B2 |
8391970 | Tracey et al. | Mar 2013 | B2 |
8406868 | Buschman et al. | Mar 2013 | B2 |
8442639 | Walker et al. | May 2013 | B2 |
8449472 | Ryu et al. | May 2013 | B2 |
8457743 | Gollasch et al. | Jun 2013 | B2 |
8457748 | Lange | Jun 2013 | B2 |
8463392 | Aghassian | Jun 2013 | B2 |
8467884 | Chen et al. | Jun 2013 | B2 |
8478414 | Kieval et al. | Jul 2013 | B2 |
8498704 | Shuros et al. | Jul 2013 | B2 |
8504161 | Kornet et al. | Aug 2013 | B1 |
8509919 | Yoo et al. | Aug 2013 | B2 |
8521293 | Anderson et al. | Aug 2013 | B2 |
8538535 | Gross et al. | Sep 2013 | B2 |
8538542 | Knudson et al. | Sep 2013 | B2 |
8560076 | Kieval et al. | Oct 2013 | B2 |
8571654 | Libbus et al. | Oct 2013 | B2 |
8571664 | Anderson et al. | Oct 2013 | B2 |
8577458 | Libbus et al. | Nov 2013 | B1 |
8577548 | Miller et al. | Nov 2013 | B2 |
8600505 | Libbus et al. | Dec 2013 | B2 |
8600511 | Yared et al. | Dec 2013 | B2 |
8600521 | Armstrong et al. | Dec 2013 | B2 |
8606359 | Rossing et al. | Dec 2013 | B2 |
8612014 | Rahman et al. | Dec 2013 | B2 |
8620422 | Kieval et al. | Dec 2013 | B2 |
8620450 | Tockman et al. | Dec 2013 | B2 |
8626290 | Dagan et al. | Jan 2014 | B2 |
8626299 | Gross et al. | Jan 2014 | B2 |
8630709 | Libbus et al. | Jan 2014 | B2 |
8634927 | Olson et al. | Jan 2014 | B2 |
8634928 | O'Driscoll et al. | Jan 2014 | B1 |
8639327 | Zhou et al. | Jan 2014 | B2 |
8639339 | Bange et al. | Jan 2014 | B2 |
8644928 | Takata | Feb 2014 | B2 |
8660666 | Craig | Feb 2014 | B2 |
8663103 | Causey, III et al. | Mar 2014 | B2 |
8670835 | Park et al. | Mar 2014 | B2 |
8692717 | Friedman | Apr 2014 | B2 |
8700145 | Kilgard et al. | Apr 2014 | B2 |
8700157 | Goetz et al. | Apr 2014 | B2 |
8700173 | Edlund | Apr 2014 | B2 |
8706223 | Zhou et al. | Apr 2014 | B2 |
8712531 | Kieval et al. | Apr 2014 | B2 |
8729129 | Tracey et al. | May 2014 | B2 |
8731663 | Bianchi et al. | May 2014 | B2 |
8738126 | Craig | May 2014 | B2 |
8744586 | Georgakopoulos et al. | Jun 2014 | B2 |
8755907 | Kieval et al. | Jun 2014 | B2 |
8788028 | Kumar et al. | Jul 2014 | B2 |
8788066 | Cates et al. | Jul 2014 | B2 |
8805513 | Libbus | Aug 2014 | B2 |
8818508 | Scheiner | Aug 2014 | B2 |
8818524 | Hincapie Ordonez et al. | Aug 2014 | B2 |
8880185 | Hastings et al. | Nov 2014 | B2 |
8929990 | Moffitt et al. | Jan 2015 | B2 |
20010044434 | Lee et al. | Nov 2001 | A1 |
20020016615 | Dev et al. | Feb 2002 | A1 |
20020026228 | Schauerte | Feb 2002 | A1 |
20020032468 | Hill et al. | Mar 2002 | A1 |
20020055764 | Malonek et al. | May 2002 | A1 |
20020077554 | Schwartz et al. | Jun 2002 | A1 |
20020089458 | Allen et al. | Jul 2002 | A1 |
20020103454 | Sackner et al. | Aug 2002 | A1 |
20020161377 | Rabkin | Oct 2002 | A1 |
20020169413 | Keren et al. | Nov 2002 | A1 |
20020198571 | Puskas | Dec 2002 | A1 |
20030036773 | Whitehurst et al. | Feb 2003 | A1 |
20030050683 | Boutos | Mar 2003 | A1 |
20030055465 | Ben-Haim et al. | Mar 2003 | A1 |
20030055466 | Ben-Haim et al. | Mar 2003 | A1 |
20030055467 | Ben-Haim et al. | Mar 2003 | A1 |
20030060858 | Kieval et al. | Mar 2003 | A1 |
20030109914 | Westlund et al. | Jun 2003 | A1 |
20030130715 | Boutos | Jul 2003 | A1 |
20030199806 | Kieval | Oct 2003 | A1 |
20030204206 | Padua et al. | Oct 2003 | A1 |
20040010303 | Bolea et al. | Jan 2004 | A1 |
20040015205 | Whitehurst et al. | Jan 2004 | A1 |
20040019364 | Kieval et al. | Jan 2004 | A1 |
20040039417 | Soykan et al. | Feb 2004 | A1 |
20040044393 | Yarden et al. | Mar 2004 | A1 |
20040054384 | Nachum | Mar 2004 | A1 |
20040064090 | Keren et al. | Apr 2004 | A1 |
20040082948 | Stewart et al. | Apr 2004 | A1 |
20040106954 | Whitehurst et al. | Jun 2004 | A1 |
20040106976 | Bailey et al. | Jun 2004 | A1 |
20040111006 | Alferness et al. | Jun 2004 | A1 |
20040133240 | Adams et al. | Jul 2004 | A1 |
20040162590 | Whitehurst et al. | Aug 2004 | A1 |
20040210261 | King et al. | Oct 2004 | A1 |
20040254616 | Rossing et al. | Dec 2004 | A1 |
20050027346 | Arkusz et al. | Feb 2005 | A1 |
20050033407 | Weber et al. | Feb 2005 | A1 |
20050049680 | Fischell et al. | Mar 2005 | A1 |
20050049686 | Gray et al. | Mar 2005 | A1 |
20050065592 | Holzer | Mar 2005 | A1 |
20050090867 | Lapanashvili et al. | Apr 2005 | A1 |
20050096710 | Kieval | May 2005 | A1 |
20050143785 | Libbus | Jun 2005 | A1 |
20050143789 | Whitehurst et al. | Jun 2005 | A1 |
20050149130 | Libbus | Jul 2005 | A1 |
20050149132 | Libbus | Jul 2005 | A1 |
20050149155 | Scheiner et al. | Jul 2005 | A1 |
20050149170 | Tassel et al. | Jul 2005 | A1 |
20050209652 | Whitehurst et al. | Sep 2005 | A1 |
20050233962 | Lue et al. | Oct 2005 | A1 |
20050240229 | Whitehurst et al. | Oct 2005 | A1 |
20050251212 | Kieval et al. | Nov 2005 | A1 |
20050283184 | Gilson et al. | Dec 2005 | A1 |
20050288651 | VanTassel et al. | Dec 2005 | A1 |
20060004417 | Rossing et al. | Jan 2006 | A1 |
20060004420 | Rossing et al. | Jan 2006 | A1 |
20060004430 | Rossing et al. | Jan 2006 | A1 |
20060074453 | Kieval et al. | Apr 2006 | A1 |
20060100668 | Ben-David et al. | May 2006 | A1 |
20060111626 | Rossing et al. | May 2006 | A1 |
20060149124 | Forsell | Jul 2006 | A1 |
20060149345 | Boggs et al. | Jul 2006 | A1 |
20060167540 | Masters et al. | Jul 2006 | A1 |
20060173507 | Mrva et al. | Aug 2006 | A1 |
20060217588 | Gross et al. | Sep 2006 | A1 |
20060217772 | Libbus et al. | Sep 2006 | A1 |
20060229677 | Moffitt et al. | Oct 2006 | A1 |
20060259085 | Zhang et al. | Nov 2006 | A1 |
20060265038 | Hagen et al. | Nov 2006 | A1 |
20060276844 | Alon et al. | Dec 2006 | A1 |
20060287705 | Weber | Dec 2006 | A1 |
20060293712 | Kieval et al. | Dec 2006 | A1 |
20070021673 | Arbel et al. | Jan 2007 | A1 |
20070021786 | Parnis et al. | Jan 2007 | A1 |
20070021790 | Kieval et al. | Jan 2007 | A1 |
20070021792 | Kieval et al. | Jan 2007 | A1 |
20070021794 | Kieval et al. | Jan 2007 | A1 |
20070021796 | Kieval et al. | Jan 2007 | A1 |
20070021797 | Kieval et al. | Jan 2007 | A1 |
20070021798 | Kieval et al. | Jan 2007 | A1 |
20070021799 | Kieval et al. | Jan 2007 | A1 |
20070027496 | Parnis et al. | Feb 2007 | A1 |
20070038255 | Kieval et al. | Feb 2007 | A1 |
20070038259 | Kieval et al. | Feb 2007 | A1 |
20070038260 | Kieval et al. | Feb 2007 | A1 |
20070038261 | Kieval et al. | Feb 2007 | A1 |
20070038262 | Kieval et al. | Feb 2007 | A1 |
20070049989 | Rossing et al. | Mar 2007 | A1 |
20070060972 | Kieval et al. | Mar 2007 | A1 |
20070106340 | Bolea et al. | May 2007 | A1 |
20070142879 | Greenberg et al. | Jun 2007 | A1 |
20070150009 | Kveen et al. | Jun 2007 | A1 |
20070156179 | S.E. | Jul 2007 | A1 |
20070156198 | Rossing et al. | Jul 2007 | A1 |
20070156201 | Rossing | Jul 2007 | A1 |
20070167984 | Kieval et al. | Jul 2007 | A1 |
20070185540 | Ben-Haim et al. | Aug 2007 | A1 |
20070185542 | Bolea et al. | Aug 2007 | A1 |
20070185543 | Rossing et al. | Aug 2007 | A1 |
20070191904 | Libbus et al. | Aug 2007 | A1 |
20070196428 | Glauser et al. | Aug 2007 | A1 |
20070198064 | Lapanashvili et al. | Aug 2007 | A1 |
20070248676 | Stamler et al. | Oct 2007 | A1 |
20070248850 | Heller | Oct 2007 | A1 |
20070255379 | Williams et al. | Nov 2007 | A1 |
20070276270 | Tran | Nov 2007 | A1 |
20070276459 | Rossing et al. | Nov 2007 | A1 |
20070282385 | Rossing et al. | Dec 2007 | A1 |
20070288076 | Bulkes et al. | Dec 2007 | A1 |
20070293927 | Frank et al. | Dec 2007 | A1 |
20080004673 | Rossing et al. | Jan 2008 | A1 |
20080009916 | Rossing et al. | Jan 2008 | A1 |
20080009917 | Rossing et al. | Jan 2008 | A1 |
20080021336 | Dobak | Jan 2008 | A1 |
20080046016 | Ben-David et al. | Feb 2008 | A1 |
20080046054 | Hjelle et al. | Feb 2008 | A1 |
20080051767 | Rossing et al. | Feb 2008 | A1 |
20080051849 | Ben-Haim et al. | Feb 2008 | A1 |
20080058872 | Brockway et al. | Mar 2008 | A1 |
20080058889 | Ben-Haim et al. | Mar 2008 | A1 |
20080058891 | Ben-Haim et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080077016 | Sparks | Mar 2008 | A1 |
20080082137 | Kieval et al. | Apr 2008 | A1 |
20080097540 | Bolea et al. | Apr 2008 | A1 |
20080119898 | Ben-David et al. | May 2008 | A1 |
20080119911 | Rosero | May 2008 | A1 |
20080132972 | Shuros et al. | Jun 2008 | A1 |
20080140167 | Hagen et al. | Jun 2008 | A1 |
20080147168 | Ransbury et al. | Jun 2008 | A1 |
20080154349 | Rossing et al. | Jun 2008 | A1 |
20080161865 | Hagen | Jul 2008 | A1 |
20080161887 | Hagen | Jul 2008 | A1 |
20080167690 | Cody et al. | Jul 2008 | A1 |
20080167693 | Kieval et al. | Jul 2008 | A1 |
20080167694 | Bolea et al. | Jul 2008 | A1 |
20080167696 | Cates et al. | Jul 2008 | A1 |
20080167699 | Kieval et al. | Jul 2008 | A1 |
20080171923 | Bolea et al. | Jul 2008 | A1 |
20080172101 | Bolea et al. | Jul 2008 | A1 |
20080172104 | Kieval et al. | Jul 2008 | A1 |
20080177364 | Bolea et al. | Jul 2008 | A1 |
20080183254 | Bly et al. | Jul 2008 | A1 |
20080195174 | Walker et al. | Aug 2008 | A1 |
20080215117 | Gross | Sep 2008 | A1 |
20090036975 | Ward et al. | Feb 2009 | A1 |
20090062874 | Tracey et al. | Mar 2009 | A1 |
20090112285 | Cahan et al. | Apr 2009 | A1 |
20090160716 | Rhodes et al. | Jun 2009 | A1 |
20090171425 | Dahlberg | Jul 2009 | A1 |
20090198097 | Gross | Aug 2009 | A1 |
20090198308 | Gross et al. | Aug 2009 | A1 |
20090204170 | Hastings et al. | Aug 2009 | A1 |
20090228078 | Zhang et al. | Sep 2009 | A1 |
20090248133 | Bloom et al. | Oct 2009 | A1 |
20090270951 | Kallmyer | Oct 2009 | A1 |
20100004650 | Ormsby et al. | Jan 2010 | A1 |
20100010556 | Zhao et al. | Jan 2010 | A1 |
20100042186 | Ben-David et al. | Feb 2010 | A1 |
20100052668 | Gleich et al. | Mar 2010 | A1 |
20100076247 | Zilbershlag et al. | Mar 2010 | A1 |
20100094373 | Sharma | Apr 2010 | A1 |
20100211131 | Williams et al. | Aug 2010 | A1 |
20100280568 | Bulkes | Nov 2010 | A1 |
20100280593 | Richter | Nov 2010 | A1 |
20100305392 | Gross et al. | Dec 2010 | A1 |
20110106237 | Bonsignore et al. | May 2011 | A1 |
20110118773 | Gross et al. | May 2011 | A1 |
20110137370 | Gross et al. | Jun 2011 | A1 |
20110301760 | Shuster et al. | Dec 2011 | A1 |
20120003569 | Kawamura et al. | Jan 2012 | A1 |
20120035679 | Dagan et al. | Feb 2012 | A1 |
20120035711 | Gross et al. | Feb 2012 | A1 |
20120158081 | Gross et al. | Jun 2012 | A1 |
20120303112 | Armstrong et al. | Nov 2012 | A1 |
20130043736 | Zilbershlag | Feb 2013 | A1 |
20130123880 | Dagan et al. | May 2013 | A1 |
20130310629 | Lafontaine | Nov 2013 | A1 |
20130338748 | Dagan | Dec 2013 | A1 |
20140031607 | Zilbershlag et al. | Jan 2014 | A1 |
20140081154 | Toth | Mar 2014 | A1 |
Number | Date | Country |
---|---|---|
0109935 | May 1984 | EP |
0791341 | Aug 1997 | EP |
WO-99026530 | Jun 1999 | WO |
WO-00002501 | Jan 2000 | WO |
WO-0226314 | Apr 2002 | WO |
WO-03076008 | Sep 2003 | WO |
WO-03082080 | Oct 2003 | WO |
WO-03082403 | Oct 2003 | WO |
WO-04014456 | Feb 2004 | WO |
WO-04073484 | Sep 2004 | WO |
WO-05032414 | Apr 2005 | WO |
WO-2005065771 | Jul 2005 | WO |
WO-05084389 | Sep 2005 | WO |
WO-05097256 | Oct 2005 | WO |
WO-06012033 | Feb 2006 | WO |
WO-06012050 | Feb 2006 | WO |
WO-06032902 | Mar 2006 | WO |
WO-06041664 | Apr 2006 | WO |
WO-06064503 | Jun 2006 | WO |
WO-06089739 | Aug 2006 | WO |
WO-2006098928 | Sep 2006 | WO |
WO-06094273 | Sep 2006 | WO |
WO-06123346 | Nov 2006 | WO |
WO-06125163 | Nov 2006 | WO |
WO-07013065 | Feb 2007 | WO |
WO-07047152 | Apr 2007 | WO |
WO-07064895 | Jun 2007 | WO |
WO-07106533 | Sep 2007 | WO |
WO-07113818 | Oct 2007 | WO |
WO-07113883 | Oct 2007 | WO |
WO-07114860 | Oct 2007 | WO |
WO-07118090 | Oct 2007 | WO |
WO-07136850 | Nov 2007 | WO |
WO-07136851 | Nov 2007 | WO |
WO-08039982 | Apr 2008 | WO |
WO-08083120 | Jul 2008 | WO |
WO-08083235 | Jul 2008 | WO |
WO-2009017647 | Feb 2009 | WO |
WO-09095920 | Aug 2009 | WO |
WO-10118126 | Oct 2010 | WO |
WO-2012017437 | Feb 2012 | WO |
WO-2012085907 | Jun 2012 | WO |
WO-2013035092 | Mar 2013 | WO |
WO-2013069020 | May 2013 | WO |
WO-2013164829 | Nov 2013 | WO |
Entry |
---|
“Stent”, Free Online Medical Dictionary, pp. 1-3, accessed Jul. 17, 2013. (Year: 2013). |
U.S. Appl. No. 60/721,728, filed Sep. 28, 2005. |
U.S. Appl. No. 60/702,491, filed Jul. 25, 2005. |
Evaluation of Cardiovascular Stents as Antennas for Implantable Wireless Applications, by Chow, IEEE Transactions on Microwave Theory and Techniques, vol. 57, No. 10, Oct. 2009. |
Office Action dated Mar. 15, 2012, which issued during the prosecution of U.S. Appl. No. 12/792,227. |
Office Action dated Aug. 9, 2011, which issued during the prosecution of U.S. Appl. No. 12/023,896. |
Cardiovascular Stents as Antennas for Implantable Wireless Applications, by Ebrish, BMEN 5151, Apr. 29, 2010. |
Office Action dated Mar. 3, 2012, which issued during the prosecution of U.S. Appl. No. 12/023,896. |
Office Action dated Dec. 19, 2011, which issued during the prosecution of U.S. Appl. No. 11/995,904. |
Office Action dated Nov. 18, 2009, which issued during the prosecution of U.S. Appl. No. 12/023,900. |
International Search Report and Written Opinion dated Dec. 19, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000636. |
International Search Report dated Jan. 24, 2007, which issued during the prosecution of Applicant's PCT/IL06/00856. |
International Search Report and Written Opinion dated May 12, 2009, which issued during the prosecution of Applicant's PCT/IL09/00115. |
International Search Report and Written Opinion dated Jul. 13, 2009, which issued during the prosecution of Applicant's PCT/IL09/00117. |
International Preliminary Report on Patentability dated Jan. 24, 2007, which issued during the prosecution of Applicant's PCT/IL06/00856. |
International Preliminary Report on Patentability dated Aug. 3, 2010, which issued during the prosecution of Applicant's PCT/IL09/00117. |
International Preliminary Report on Patentability dated Aug. 3, 2010, which issued during the prosecution of Applicant's PCT/IL09/00115. |
Hamilton, Coronary vascular sympathetic beta-receptor innervations,, American Journal of Physiology, vol. 230, No. 6, Jun. 1976. |
International Search Report and a Written Opinion dated Mar. 5, 2013, which issued during the prosecution of Applicant's PCT/IL12/00336. |
Matheny, Vagus nerve stimulation as a method to temporarily slow or arrest the heart, Ann Thorac Surg. Jun. 1997;63(6 Suppl):S28-9. Abstract only. |
Lewis, Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart, J Physiol. Jul. 15, 2001; 534(Pt 2): 547-552. |
Laitinen, Am J, Sympathovagal balance is major determinant of short-term blood pressure variability in healthy subjects, Physiol Heart Circ Physiol 276:1245-1252, 1999. |
Frost MC, Preparation and characterization of implantable sensors with nitric oxide release coatings, Microchemical Journal vol. 74 Issue: 3, Jun. 2003 pp. 277-288. |
Baudrie, Am J, Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice, Physiol Regul Integr Comp Physiol 292: R904-R912, 2007. |
Kugiyama K, Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina, Circulation 94:266-272 (1996). |
Malpas, Neural influences on cardiovascular variability: possibilities and pitfalls,, Am J Physiol Heart Circ Physiol 282: H6-H20, 2002. |
Shin Jae Ho, “Improving the biocompatibility of in vivo sensors via nitric oxide release,” Analyst, 2006, 131, 609-615. |
Zhao et al., Loss of nitric oxide production in the coronary circulation after the development of dilated cardiomyopathy: a specific defect in the neural regulation of coronary blood flow, Clinical and Experimental Pharmacology and Physiology 23(8): 715-721 (1996). |
Sherman et al., Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo, Circulation 95:1328-1334 (1997). |
Schoenfisch et al., “Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters”, Anal. Chem., 72 (6), 1119-1126, 2000. |
Paulus, “Beneficial effects of nitric oxide on cardiac diastolic function: the flip side of the coin”, Heart Failure Review 5(4):337-344 (2000). |
Web page relating to EndoSure® Wireless AAA Pressure Measurement System, manufactured by CardioMEMS, Inc. (downloaded on Nov. 30, 2010 from: <http://www.cardiomems.com/content.asp?display=medical+mb&expand=ess>. |
Cheetah Medical Inc. manufactures the Cheetah Reliant, Jan. 23, 2008. |
SULZER IntarTeraputic Inc. manufactures the IntraCoil® Self-Expanding Peripheral Sent (IntraCoil® Sent), Jun. 28, 2002. |
Hayashida et al., “Comparison of neurogenic contraction and relaxation in canine corpus cavernosum and penile artery and vein”, J. Pharmacol. 72:231-240 (1996), p. 232 col. 2, para. 1; p. 238, col. 2, para 2. |
Biosense Webster, Inc. (CA, USA) manufactures the LASSO 2515 Variable Circular Mapping Catheter, 2010. |
Wustmann, “Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension”, Hypertension 2009; 54;530-536. |
Yao Sheng-Kun, “Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reclusion after thrombolysis” Circulation. 1995;92 pp. 1005-1010. |
“Heart rate variability,” by Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, European Heart Journal (1996) 17, 354-381. |
Vallais, “Heart rate and vasomotor control during exercise”, Proceedings of the 29th Annual International Conference of the IEEE EMBS, Cité Internationale, Lyon, France, Aug. 23-26, 2007. |
Sabbah H et al., “Global left ventricular remodeling with the Acorn Cardiac Support Device: Hemodynamic and angiographic findings in dogs with heart failure” Heart Failure Reviews 10(2):109-115 (2005) first page. |
Kass D., Eur Heart J. Nov. 1992;13 Suppl. E:57-64. |
Steendijk et al., European Heart Journal (2004) 6 (Supplement D), D35-D42. |
Suga et al., Am J Physiol. Jan. 1981; 240(1):H39-44. |
Kong et al. “Tumour necrosis factor-α and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats”. Clin Exp Pharmacol Physiol. 2011; 38:300-6. |
Uemura et al., “Early short-term vagal nerve stimulation attenuates cardiac remodeling after reperfused myocardial infarction”. J Card Fail. Aug. 2010;16(8):689-99. |
Katare et al. “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect”. J Thorac Cardiovasc Surg. Jan. 2009;137(1):223-31. |
Kawada et al. “Vagal stimulation suppresses ischemia-induced myocardial interstitial myoglobin release”. Life Sci. Sep. 26, 2008;83(13-14):490-5. |
Uemura et al. “Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit”. Am J Physiol Heart Circ Physiol. Oct. 2007;293(4):H2254-61. |
Mioni et al. “Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats”. Crit Care Med. Nov. 2005;33(11):2621-8. |
Office Action dated Jun. 19, 2012, which issued during the prosecution of U.S. Appl. No. 11/995,904. |
Office Action dated Aug. 29, 2012, which issued during the prosecution of U.S. Appl. No. 12/792,227. |
U.S. Appl. No. 61/331,453, filed May 5, 2010. |
Office Action dated Aug. 1, 2012, which issued during the prosecution of U.S. Appl.n No. 12/957,799. |
International Search Report and Written Opinion dated Jul. 5, 2012, which issued during the prosecution of Applicant's PCT/IL11/00952. |
Notice of Allowance dated Sept 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/210,778. |
Office Action dated Oct. 2, 2012, which issued during the prosecution of U.S. Appl. No. 12/851,214. |
Office Action dated Sep. 18, 2012, which issued during the prosecution of U.S. Appl. No. 12/023,896. |
English Translation of an Office Action dated Oct. 8, 2012, which issued during the prosecution of Chinese Patent Application No. 200980111617.8. |
Office Action dated Jul. 18, 2012, which issued during the prosecution of U.S. Appl. No. 13/210,778. |
Office Action dated Mar. 12, 2013, which issued during the prosecution of U.S. Appl. No. 13/210,778. |
Supplementary European search Report dated Dec. 14, 2012, which issued during the prosecution of European Patent Application No. 06766171. |
Office Action dated Apr. 25, 2013, which issued during the prosecution of U.S. Appl. No. 11/995,904. |
Office Action dated May 10, 2013, which issued during the prosecution of U.S. Appl. No. 12/023,896. |
Office Action dated Apr. 5, 2013, which issued during the prosecution of U.S. Appl. No. 12/792,227. |
Takahata, “Stentenna: A Micromachined Antenna Stent for Wireless Monitoring of Implantable Microsensors” Engineering in Med. and Biol. Soci, 2003. Proceedings of the 25th Annual Intern Conference of the IEEE Sep. 17-21, 2003. |
U.S. Appl. No. 61/532,660, filed Sep. 9, 2011. |
U.S. Appl. No. 61/183,319, filed Jun. 2, 2009. |
Taylor, The unequal influences of the left and right vagi on the control of the heart and pulmonary artery in the rattlesnake, Crotalus durissus, The Journal of Experimental Biology 212, pp. 145-151, 2009. |
An Office Action dated Dec. 13, 2013, which issued during the procesution of U.S. Appl. No. 13/294,062. |
An Office Action dated Jan. 27, 2014, which issued during the prosecution of U.S. Appl. No. 12/023,896. |
Extended European Search Report dated Oct. 31, 2013, which issued during the prosecution of European Application No. 11814203.3. |
An Office Action dated Nov. 12, 2013, which issued during the prosecution of U.S. Appl. No. 11/995,904. |
An Office Action dated Dec. 20, 2013, which issued during the prosecution of U.S. Appl. No. 12/792,227. |
Hennig et al., “Analysis of Power Absorption by Human Tissue in Deeply Implantable Medical Sensor Transponders”, pp. 407-420, Advanced Microwave Circuits and Systems, Published onlihe Apr. 1, 2010. |
Gabriel et al., “The Dielectric Properties of Biological Tissues: II. Measurements in the frequency range 10 Hz to 20 GHz”, Phys. Med. Biol. 41 (1996) pp. 2251-2269. |
Office Action dated Jan. 5, 2015 issued during the prosecution of U.S. Appl. No. 12/959,126. |
Office Action dated Jan. 15, 2015 issued during prosecution of U.S. Appl. No. 14/356,829. |
PCT International Search Report and Written Opinion dated Apr. 16, 2015, issued on corresponding PCT International Application No. PCT/IL2014/50972 (16 pages). |
Extended European Search Report dated Jun. 29, 2016, issued during the prosecution of European Patent Application No. 12830322.9. (8 pages). |
Office Action dated Jan. 4, 2016, issued during the prosecution of U.S. Appl. No. 13/741,154 (11 pages). |
Office Action dated May 22, 2015, issued during the prosecution of U.S. Appl. No. 13/741,154 (8 pages). |
Office Action dated Nov. 7, 2014 issued during the prosecution of U.S. Appl. No. 13/741,154 (18 pages). |
An Office Action dated May 16, 2018, which issued during the prosecution of U.S. Appl. No. 15/034.803. |
An Office Action dated Sep. 12, 2018, which issued during the prosecution of U.S. Appl. No. 14/486,081. |
An Office Action dated Aug. 7, 2019, which issued during the prosecution of U.S. Appl. No. 15/034,803. |
Number | Date | Country | |
---|---|---|---|
20170065824 A1 | Mar 2017 | US |
Number | Date | Country | |
---|---|---|---|
61532660 | Sep 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13741154 | US | |
Child | 15354313 | US |